NCT04272606View on ClinicalTrials.gov

TXA in Spinal Fusion

PHASE2CompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

June 12, 2023

Study Completion Date

June 12, 2023

Conditions
Degenerative Disc Disease
Interventions
DRUG

Tranexamic Acid

Antifibrinolytic Agent

DRUG

Saline Solution

Placebo

DIAGNOSTIC_TEST

Visual Acuity Exam

Supplemented into standard of care daily neurological exam on day of surgery and day after

DIAGNOSTIC_TEST

3 Minute Diagnostic Interview for Confusion Assessment Method (3D-CAM)

3D-CAM is a brief verbal assessment tool that can be used to test patients and study patients for delirium.

Trial Locations (1)

52242

University of Iowa Hospitals and Clinics, Iowa City

All Listed Sponsors
lead

Catherine R. Olinger

OTHER

NCT04272606 - TXA in Spinal Fusion | Biotech Hunter | Biotech Hunter